221. Antibody Drug Conjugates (ADCs) Dato Potato
This episode explores Antibody Drug Conjugates (ADCs) in breast cancer treatment, discussing their mechanism, approved examples like Enhertu and Trodelvy, and trials for Datopotamab Deruxtecan. It also covers side effect management and future developments in ADC therapy.